Carmen Sapienza

Carmen Sapienza

Auto-generated profile, based on publicly available information

Carmen Sapienza

Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2008 in JAMA
Verified
Journal Article
Open access
PDF file
HBHans Tomas Bjornsson
Hans Tomas Bjornsson
MSMartin I. Sigurdsson
Martin I. Sigurdsson
MFM. Daniele Fallin
M. Daniele Fallin
RIRafael A. Irizarry
Rafael A. Irizarry
TAThor Aspelund
Thor Aspelund
AFAndrew P. Feinberg
Andrew P. Feinberg
Epigenetic marks are modifications of DNA or associated proteins, other than the DNA sequence itself, that are heritable through cell division. These include DNA methylation, a covalent modification of cytosine; histone modifications affecting the nucleosomes around which the DNA is coiled; and alterations in nucleosomal packing or higher-order folding of chromatin. We and others have suggested that epigenetics might play a role in the etiology of common human diseases.1-3 In a recent review in JAMA by 1 of us (A.P.F.), it was noted that epigenetics stands at the epicenter of modern medicine because it unites nuclear reprogramming during development, environmentally induced changes on the body, and the ability of cells to respond appropriately to external stimuli.4 That is because epigenetic changes, unlike the DNA sequence, distinguish one tissue type from another and dietary and other environmental exposures alter the epigenetic program; the ability of genes to alter their expression is controlled by epigenetic factors such as DNA methylation.5,6 Diseases in which epigenetic change has been shown to play a major role include cancer and some disorders of the immune system, and epigenetic defects may also contribute to chronic diseases such as diabetes, bipolar disorder, and autism and loss of normal responsiveness to stress that accompanies aging.7-9

15 July 2009 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
SKSunita Katari
Sunita Katari
NTNahid Turan
Nahid Turan
MBMarina Bibikova
Marina Bibikova
OEOluwatoyin Erinle
Oluwatoyin Erinle
RCRaffi Chalian
Raffi Chalian
CSCarmen Sapienza
Carmen Sapienza
Epidemiological data indicate that children conceived in vitro have a greater relative risk of low birth-weight, major and minor birth defects, and rare disorders involving imprinted genes, suggesting that epigenetic changes may be associated with assisted reproduction. We examined DNA methylation at more than 700 genes (1536 CpG sites) in placenta and cord blood and measured gene expression levels of a subset of genes that differed in methylation levels between children conceived in vitro versus in vivo. Our results suggest that in vitro conception is associated with lower mean methylation at CpG sites in placenta and higher mean methylation at CpG sites in cord blood. We also find that in vitro conception-associated DNA methylation differences are associated with gene expression differences at both imprinted and non-imprinted genes. The range of inter-individual variation in gene expression of the in vitro and in vivo groups overlaps substantially but some individuals from the in vitro group differ from the in vivo group mean by more than two standard deviations. Several of the genes whose expression differs between the two groups have been implicated in chronic metabolic disorders, such as obesity and type II diabetes. These findings suggest that there may be epigenetic differences in the gametes or early embryos derived from couples undergoing treatment for infertility. Alternatively, assisted reproduction technology may have an effect on global patterns of DNA methylation and gene expression. In either case, these differences or changes may affect long-term patterns of gene expression.

1 January 2011 in Epigenetics
Verified
Journal Article
Closed access
CSCarmen Sapienza
Carmen Sapienza
JLJean Lee
Jean Lee
JPJasmine Powell
Jasmine Powell
OEOluwatoyin Erinle
Oluwatoyin Erinle
FYFaahud Yafai
Faahud Yafai
MMMichael Madaio
Michael Madaio
We identified potential epigenetic biomarkers for chronic kidney disease progression by comparing site-specific DNA methylation levels in more than 14,000 genes between African American and Hispani...

17 July 2016 in Annual Review of Nutrition
Verified
Journal Article
Closed access
CSCarmen Sapienza
Carmen Sapienza
JIJean-Pierre Issa
Jean-Pierre Issa
The search for a connection between diet and human cancer has a long history in cancer research, as has interest in the mechanisms by which dietary factors might increase or decrease cancer risk. The realization that altering diet can alter the epigenetic state of genes and that these epigenetic alterations might increase or decrease cancer risk is a more modern notion, driven largely by studies in animal models. The connections between diet and epigenetic alterations, on the one hand, and between epigenetic alterations and cancer, on the other, are supported by both observational studies in humans as well as animal models. However, the conclusion that diet is linked directly to epigenetic alterations and that these epigenetic alterations directly increase or decrease the risk of human cancer is much less certain. We suggest that true and measurable effects of diet or dietary supplements on epigenotype and cancer risk are most likely to be observed in longitudinal studies and at the extremes of the intersection of dietary risk factors and human population variability. Careful analysis of such outlier populations is most likely to shed light on the molecular mechanisms by which suspected environmental risk factors drive the process of carcinogenesis.

22 July 2010 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
NTNahid Turan
Nahid Turan
SKSunita Katari
Sunita Katari
LGLeigh F. Gerson
Leigh F. Gerson
RCRaffi Chalian
Raffi Chalian
MFMichael W. Foster
Michael W. Foster
CSCarmen Sapienza
Carmen Sapienza
Epidemiological studies have reported a higher incidence of rare disorders involving imprinted genes among children conceived using assisted reproductive technology (ART), suggesting that ART procedures may be disruptive to imprinted gene methylation patterns. We examined intra- and inter-individual variation in DNA methylation at the differentially methylated regions (DMRs) of the IGF2/H19 and IGF2R loci in a population of children conceived in vitro or in vivo. We found substantial variation in allele-specific methylation at both loci in both groups. Aberrant methylation of the maternal IGF2/H19 DMR was more common in the in vitro group, and the overall variance was also significantly greater in the in vitro group. We estimated the number of trophoblast stem cells in each group based on approximation of the variance of the binomial distribution of IGF2/H19 methylation ratios, as well as the distribution of X chromosome inactivation scores in placenta. Both of these independent measures indicated that placentas of the in vitro group were derived from fewer stem cells than the in vivo conceived group. Both IGF2 and H19 mRNAs were significantly lower in placenta from the in vitro group. Although average birth weight was lower in the in vitro group, we found no correlation between birth weight and IGF2 or IGF2R transcript levels or the ratio of IGF2/IGF2R transcript levels. Our results show that in vitro conception is associated with aberrant methylation patterns at the IGF2/H19 locus. However, very little of the inter- or intra-individual variation in H19 or IGF2 mRNA levels can be explained by differences in maternal DMR DNA methylation, in contrast to the expectations of current transcriptional imprinting models. Extraembryonic tissues of embryos cultured in vitro appear to be derived from fewer trophoblast stem cells. It is possible that this developmental difference has an effect on placental and fetal growth. We have screened a population of children conceived in vitro for epigenetic alterations at two loci that carry parent-of-origin specific methylation marks. We made the observation that epigenetic variability was greater in extraembryonic tissues than embryonic tissues in both groups, as has also been demonstrated in the mouse. The greater level of intra-individual variation in extraembryonic tissues of the in vitro group appears to result from these embryos having fewer trophoblast stem cells. We also made the unexpected observation that variability in parental origin-dependent epigenetic marking was poorly correlated with gene expression. In fact, there is such a high level of inter-individual variation in IGF2 transcript level that the presumed half-fold reduction in IGF2 mRNA accounted for by proper transcriptional imprinting versus complete loss of imprinting would account for less than 5% of the total population variance. Given this level of variability in the expression of an imprinted gene, the presumed operation of “parental conflict” as the selective force acting to maintain imprinted gene expression at the IGF2/H19 locus in the human should be revisited.

27 February 2001 in Mammalian Genome
Verified
Journal Article
Closed access
PDF file
FVFernando Pardo-Manuel de Villena
Fernando Pardo-Manuel de Villena
CSCarmen Sapienza
Carmen Sapienza